Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this bioequivalence study is to compare a test Glimepiride 1 mg tablets of
Dr.Reddy's Laboratories Limited versus reference Amaryl 1 mg tablets of Aventis
Pharmaceuticals Inc in healthy subjects, under fasting condition.